Fei Ling holds a PhD in stem cell and cancer immunotherapy, with her research focusing on genetically engineered stem cells and their interactions with immune cells to combat breast cancer. She has experience as a lecturer at International Medical University and SEGI University in Malaysia, and gained expertise in iPSC technology during attachments at CiRA, Kyoto, and NIH Malaysia. Currently at the University of Nottingham Malaysia, Fei Ling’s research interests include cell-based therapy, stem cells, and cancer immunotherapy. She is dedicated to continuously advancing her knowledge and skills in innovative academic and research fields.